Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.80
-0.04 (-0.31%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Korro Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 185 | 75 | 357 | 383 | - | - |
| Market Cap Growth | 52.42% | -78.85% | -6.96% | - | - | - |
| Enterprise Value | 143 | 18 | 229 | 578 | - | - |
| Last Close Price | 12.80 | 8.01 | 38.07 | 47.93 | - | - |
| PS Ratio | 28.88 | 11.80 | 157.04 | - | - | - |
| PB Ratio | 2.34 | 1.47 | 2.22 | 2.26 | - | - |
| P/TBV Ratio | 3.59 | 1.47 | 2.22 | 2.26 | - | - |
| EV/Sales Ratio | 22.36 | 2.76 | 100.98 | - | - | - |
| Debt / Equity Ratio | 0.85 | 0.85 | 0.28 | 0.20 | 0.05 | - |
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.74 | -0.78 | -0.80 | -0.97 |
| Net Debt / EBITDA Ratio | 0.50 | 0.50 | 1.34 | 1.64 | 0.92 | 3.50 |
| Net Debt / FCF Ratio | 0.53 | 0.53 | 1.52 | 1.77 | 0.89 | 3.24 |
| Asset Turnover | 0.04 | 0.04 | 0.01 | - | - | - |
| Quick Ratio | 6.38 | 6.38 | 8.54 | 8.53 | 6.35 | 23.95 |
| Current Ratio | 6.90 | 6.90 | 8.79 | 8.87 | 6.56 | 24.20 |
| Return on Equity (ROE) | -110.70% | -110.70% | -50.60% | -69.16% | -62.24% | - |
| Return on Assets (ROA) | -32.14% | -32.14% | -25.65% | -35.77% | -36.63% | - |
| Return on Capital Employed (ROCE) | -86.00% | -86.00% | -43.50% | -41.80% | -90.70% | -28.90% |
| Earnings Yield | -63.52% | -155.45% | -23.43% | -21.18% | - | - |
| FCF Yield | -42.84% | -104.83% | -21.86% | -19.60% | - | - |
| Buyback Yield / Dilution | -5.32% | -5.32% | -483.30% | -499.32% | 94.26% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.